Internal Medicine | Page 223 of 487 | Links Medicus Content Curation & Alerts in Medicine

Cohort study finds differences in #PalliativeCare for cancer vs noncancer patients: Earlier initiation/Multiple settings/Shared care. Need to improve equitable access to care across all settings @CanadianHPCAssn @AAHPM @HQOntario @ICESOntario @SinaiHealth https://t.co/b7i4z8zokq

— JAMA Network Open (@JAMANetworkOpen) March 5, 2021

USPSTF Statement: begin screening for lung cancer at age 50 years instead of 55 years for patients at risk

10 Mar, 2021 | 08:28h | UTC

Recommendation Statement: Screening for Lung Cancer – US Preventive Services Task Force

Editorials: Broadened Eligibility for Lung Cancer Screening: Challenges and Uncertainty for Implementation and Equity – JAMA AND Expanded Access to Lung Cancer Screening—Implementing Wisely to Optimize Health – JAMA Network Open AND New USPSTF Guidelines for Lung Cancer Screening: Better but Not Enough – JAMA Surgery AND The 2021 US Preventive Services Task Force Recommendation on Lung Cancer Screening: The More Things Stay the Same… – JAMA Oncology

Cohort study: Hypertensive disorders of pregnancy linked to subsequent risk of premature mortality

10 Mar, 2021 | 08:24h | UTC

Hypertensive Disorders of Pregnancy and Subsequent Risk of Premature Mortality – Journal of the American College of Cardiology (link to abstract – $ for full-text)

Commentaries: Do Hypertension Disorders of Pregnancy Increase Risk of Premature Maternal Mortality? – American College of Cardiology AND Hypertension disorders of pregnancy increase risk of premature maternal mortality – American College of Cardiology

[Press release – not published yet] Monoclonal antibodies reduced hospitalizations and death in Phase 3 trial for early COVID-19

11 Mar, 2021 | 08:41h | UTC

Press release: Lilly’s bamlanivimab and etesevimab together reduced hospitalizations and death in Phase 3 trial for early COVID-19

Commentary: Eli Lilly’s combo therapy for COVID-19 cuts serious illness and death in large study – Reuters

Death rate 64% higher with B117 COVID variant, study finds

11 Mar, 2021 | 08:38h | UTC

Death rate 64% higher with B117 COVID variant, study finds – CIDRAP

News release: Variant B.1.1.7 of COVID-19 associated with a significantly higher mortality rate, research shows – University of Bristol

Original Study: Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study – The BMJ

Study from 116 countries suggests surgery should be delayed for at least seven weeks following a COVID-19 diagnosis to reduce mortality risk

11 Mar, 2021 | 08:35h | UTC

Study from 116 countries suggests surgery should be delayed for at least seven weeks following a COVID-19 diagnosis to reduce mortality risk – Association of Anaesthetists of Great Britain and Ireland

Original study: Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study – Anaesthesia

Commentary on Twitter

Reported by > 100 news organisations and > 200k Twitter impressions in just a few hours!

Here is the new @CovidSurg infographic! Time to establish timing of surgery guidelines?@aneelbhangu @dnepo @JoanaffSimoes #FOAMed

🔗https://t.co/mRnV7U6u1w pic.twitter.com/BmKlxf9ZIK

— 𝘈𝘯𝘢𝘦𝘴𝘵𝘩𝘦𝘴𝘪𝘢 (@Anaes_Journal) March 10, 2021

[Preprint] RECOVERY trial: Convalescent plasma does not improve outcomes in patients admitted to hospital with COVID-19

11 Mar, 2021 | 08:43h | UTC

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial – medRxiv

Commentary on Twitter (thread – click for more)

RECOVERY Pre-print:

Convalescent plasma does not improve survival in patients hospitalised with COVID-19 in this randomised controlled trial involving 11,558 patients:https://t.co/36YZwJNY3Q pic.twitter.com/sKR095n1PC

— Martin Landray (@MartinLandray) March 10, 2021

State of the Art Review | Severe covid-19 pneumonia: pathogenesis and clinical management

11 Mar, 2021 | 08:37h | UTC

Severe covid-19 pneumonia: pathogenesis and clinical management – The BMJ

Clinical Decisions | Doctor, How Long Should I Isolate?

11 Mar, 2021 | 08:21h | UTC

Doctor, How Long Should I Isolate? – New England Journal of Medicine

Attributes and predictors of long COVID

11 Mar, 2021 | 08:25h | UTC

Attributes and predictors of long COVID – Nature

Commentary on Twitter

https://twitter.com/ASPphysician/status/1369617507405946881

Audio Interview: The implications of changes in the structural biology of SARS-CoV-2

11 Mar, 2021 | 08:20h | UTC

Audio Interview: The Implications of Changes in the Structural Biology of SARS-CoV-2 – New England Journal of Medicine

More data suggesting a single dose of SARS-CoV-2 mRNA vaccine may be enough in seropositive individuals

11 Mar, 2021 | 08:18h | UTC

Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine – New England Journal of Medicine

Commentary: Second shot of COVID-19 vaccine may not be necessary in previously infected individuals: study – The Mount Sinai Hospital

Review: Autoimmune enteropathy and its associated syndromes

10 Mar, 2021 | 08:10h | UTC

A Review of Autoimmune Enteropathy and Its Associated Syndromes – Digestive Diseases and Sciences

Clinical Update: Diagnosis and Treatment of Nonscarring Hair Loss in Primary Care in 2021

10 Mar, 2021 | 08:14h | UTC

Diagnosis and Treatment of Nonscarring Hair Loss in Primary Care in 2021 – JAMA (free for a limited period)

Lab study shows Pfizer/BioNTech COVID-19 vaccine can also neutralize B.1.351, P1 and B.1.1.7 variants

10 Mar, 2021 | 08:43h | UTC

Neutralizing Activity of BNT162b2-Elicited Serum – New England Journal of Medicine

Commentaries: Expert reaction to NEJM correspondence paper looking at the neutralising activity of the Pfizer-BioNTech vaccine against SARS-CoV-2 variants in the lab – Science Media Centre AND Pfizer/BioNTech COVID-19 vaccine neutralizes Brazil variant in lab study – Reuters

Study: Home testing for COVID-19 could prevent infections and reduce deaths at justifiable cost

10 Mar, 2021 | 08:40h | UTC

News release: Home testing for COVID-19 could prevent infections and reduce deaths at justifiable cost – Yale University

Original study: Clinical and Economic Effects of Widespread Rapid Testing to Decrease SARS-CoV-2 Transmission – Annals of Internal Medicine

Commentary on Twitter

Model-based analysis by @ADPaltiel, Amy Zheng of @YaleMed and @PaulSaxMD of @BrighamWomens.

A nationwide program of frequent home testing and self-isolation could greatly reduce total #COVID19 infections and mortality at a justifiable cost https://t.co/8AglZQXpuL. pic.twitter.com/5gQV3i0NxG

— Annals of Int Med (@AnnalsofIM) March 8, 2021